Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Large prostate patients more likely to have hair loss.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Olive leaves extract may help treat benign prostatic hyperplasia (BPH).

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Cancer prevention is crucial, with a focus on research and improved screening methods.

Ivermectin 1% cream effectively reduces visible and invisible symptoms of rosacea.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Finasteride is safe for long-term use in prostate cancer treatment.